HeyJaredLee Samaha
- Indexed articles, last 90 days
- 50
- Latest publication
- Sep 17, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Jul 4, 2026
Latest articles
Warren Buffett Is Sounding Off on Market Risk and Investors Should Listen (opens the original)
Read excerpt
Warren Buffett has given a couple of interviews to CNBC in recent months that have provided some fascinating color on the state of the markets. Tangentially, they touched on the biggest debate in the market right now: the sustainability of the artificial intelligence (AI) spending boom and its implications for stocks like Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) and Oracle (NYSE: ORCL). My take on it is that there's definitely reason for near-term caution, but investors should look to take advant
Should You Ignore MP Materials and Buy This Rare-Earth Stock Instead? (opens the original)
Read excerpt
It's MP Materials (NYSE: MP) versus USA Rare Earth (NASDAQ: USAR) in the great debate over which is the leading rare-earth company that will solve the problem of securing a domestic supply. The two companies have key differences, which means they will work differently in your portfolio. Here's why, and a suggestion for how to invest in the sector. Both companies have received substantive backing from the U.S. government, and understandably so. China dominates the rare-earth market, and given the
Copper Just Soared to an All-Time High, but This Stock Is Still a Great Value (opens the original)
Read excerpt
The price of copper recently hit an all-time high, helping lift the stock of copper miner Freeport-McMoRan (NYSE: FCX). For short-term traders, that kind of news might be a cause for caution. But unless you have a strong view that copper will decline markedly from here, the stock continues to look highly attractive. Here's why. The chart below shows just how well the metal has performed in recent years and the strength of its recent run. Missed Nvidia in 2009? This Rare Signal Is Flashing Again.
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case. (opens the original)
Read excerpt
According to Yahoo! Finance, the consensus price target from analysts for Viking Therapeutics (NASDAQ: VKTX) is about $92, which indicates potential upside of 162% from its current stock price. It's a significant opportunity, but is it justified? Here's the lowdown from the skeptics' perspective. The investment case for the stock rests on its lead drug candidate, VK2735, a dual GLP-1 and GIP agonist in development for obesity and type 2 diabetes. The two key advantages VK2735 may have over its r
Newmont Stock Jumps 34.5% in August, and Gold's Rally Could Take It Higher (opens the original)
Read excerpt
Shares in Newmont Corporation (NYSE: NEM) rose 34.5% in August, according to data from S&P Global Market Intelligence. The move comes amid rising gold prices and positive news on the administrative and operational fronts regarding the resolution of a dispute with Barrick Mining Corporation (NYSE: B). In addition, I would argue that the appeal of gold as a safe-haven investment increased throughout the month. The price of gold rose throughout the month, and given the operational leverage miners h
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.